William W. Burke, a director at Ceribell, Inc. (NASDAQ:CBLL), sold 18,000 shares of common stock on November 12, 2026, for approximately $479,479, according to a regulatory filing. The shares were sold at prices ranging from $26.58 to $27.48. The transactions were executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
The sale comes after an impressive 103% gain over the past year, though an analysis suggests the stock is currently overvalued relative to its Fair Value. For deeper insights, investors can access additional ProTips and a comprehensive Pro Research Report.
The sales included 16,845 shares, which were transacted at a weighted average price of $26.58 per share, with individual prices ranging from $26.30 to $26.99. An additional 1,155 shares were sold at a weighted average price of $27.48 per share, with prices ranging from $27.34 to $27.72.
Prior to these sales, Mr. Burke acquired 18,000 shares of Ceribell common stock through the exercise of a stock option at a price of $4.70 per share, totaling $84,600. This stock option was fully vested and exercisable.
Following these reported transactions, Mr. Burke directly holds 23,022 shares of Ceribell (NASDAQ:CBLL) common stock.
In other recent news, Ceribell reported its third-quarter revenue for 2026, reaching $29.3 million, marking a 30% increase from the previous year. Despite this revenue growth, Ceribell posted a loss of $0.55 per share, which was wider than analysts’ expectations of a $0.34 loss. BTIG maintained its Buy rating on Ceribell, setting a price target of $30.00, following these financial results. The company’s product revenue reached $22.2 million, slightly above the consensus of $22.0 million, while subscription revenue was $7.1 million, just below the expected $7.2 million. These developments indicate a mixed financial performance for the company, with strong revenue growth but challenges in meeting earnings expectations.
Ceribell’s stock closed at $26.14 on November 13, down $0.21 or 0.80%.